New York's egg freezing insurance mandate is wasteful policy based on failed promises
Source: https://www.facebook.com/americanspectator/. "New York State Serves Up Insanity on Egg Freezing | The American Spectator | USA News and Politics." February 1, 2026. spectator.org
The Gist
The author argues New York shouldn't force insurance to cover egg freezing because it rarely works - only about 1 in 60 women who freeze eggs actually have a baby from them. She says it's expensive, painful, and was oversold as a way for women to delay childbearing for their careers.
Conclusion
New York State should not require insurance companies to cover egg freezing procedures for all women
Premises
- Only 1.64% of women who freeze their eggs end up with a child, according to a UCLA study of 4,153 women
- Only 5.7% of women who freeze eggs actually return to use them
- The procedure costs $18,000-$20,000 and involves significant medical risks and discomfort
- Egg freezing was originally marketed as career liberation but has largely failed to deliver on its promises
- The process creates embryos that are often discarded when unsuccessful
- Insurance companies will be forced to pay for procedures with extremely low success rates
Assumptions
- Insurance coverage should be based on medical necessity and effectiveness
- Low success rates indicate a procedure is not worth mandating coverage for
- The original marketing promises about egg freezing were misleading
- Taxpayers and insurance premium payers should not subsidize ineffective procedures
Analysis
Overall strength: Moderate. Argument type: Inductive.
Premise Strength
- Only 1.64% of women who freeze their eggs end up with a child (Strong) — Specific, recent study with large sample size provides concrete evidence
- Only 5.7% of women who freeze eggs actually return to use them (Strong) — Directly supports the low success rate claim with specific data
- The procedure costs $18,000-$20,000 and involves significant medical risks (Moderate) — Cost figure is reasonable but medical risks are not well-documented in the argument
- Egg freezing was originally marketed as career liberation but has failed (Moderate) — Anecdotal evidence from one case study, not comprehensive analysis
- Insurance companies will be forced to pay for ineffective procedures (Moderate) — Follows logically but assumes current effectiveness data won't improve
Potential Fallacies
- Cherry-picking (Primary statistical premise) — Focuses on one study's results without discussing other research or potential methodological limitations
- Appeal to consequences (Supporting premises about cost) — Argues against the policy partly based on feared outcomes for insurance companies
Counterarguments
- Low success rate premise (High impact) — Success rates may improve with advancing technology and better patient selection
- Cost-effectiveness claim (Medium impact) — Many covered medical procedures have low success rates but high value when they work
- Usage rate premise (Medium impact) — Low usage might reflect access barriers rather than lack of demand
- Overall conclusion (High impact) — Insurance should cover preventive reproductive care as part of comprehensive women's health
Suggested Improvements
- Statistical context — Compare egg freezing success rates to other fertility treatments covered by insurance Would provide better framework for evaluating cost-effectiveness
- Causation analysis — Examine why usage rates are low - is it due to life circumstances, costs, or satisfaction? Would strengthen the argument about whether the procedure serves its intended purpose
- Alternative solutions — Propose alternative policies that might better support women's reproductive choices Would make the argument more constructive rather than purely oppositional
Scenario Tests
- Technology improves and success rates double to 3.3% (Challenges) — Would weaken the core statistical argument but still leave success rates quite low
- Insurance covers other low-success fertility treatments (Challenges) — Would undermine the consistency argument about what insurance should cover
- Women report high satisfaction despite low birth rates (Challenges) — Would suggest the procedure has value beyond just live births
Coherence & Relevance
The premises work together well to support the conclusion, though the argument would benefit from more comparative context about other medical procedures and insurance coverage standards
- 1.64% success rate (Strong) — None - directly supports ineffectiveness claim
- Low usage rates (Strong) — Could explore reasons for low usage more deeply
- High costs and medical risks (Moderate) — Needs comparison to other covered procedures
- Failed marketing promises (Moderate) — More anecdotal than systematic evidence